Systematic review: second-generation vs. conventional corticosteroids for induction of remission in ulcerative colitis

Induction of clinical and colonoscopic remission of mild-to-moderate ulcerative colitis with budesonide MMX 9 mg: pooled analysis of two phase 3 studies

(2015) W. J. Sandborn et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Erratum: Corrigendum: Oral Prolonged Release Beclomethasone Dipropionate and Prednisone in the Treatment of Active Ulcerative Colitis: Results From a Double-Blind, Randomized, Parallel Group Study

(2015) Gert Van Assche et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Budesonide MMX for the Induction of Remission of Mild to Moderate Ulcerative Colitis: A Pooled Safety Analysis

(2015) Gary R. Lichtenstein et al.   Journal of Crohns & Colitis

Review article: integrating budesonide-MMX into treatment algorithms for mild-to-moderate ulcerative colitis

(2014) S. Danese et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

The role of Budesonide-MMX in active ulcerative colitis

(2014) Paolo Gionchetti et al.   Expert Review of Gastroenterology & Hepatology

Low bioavailability steroids in inflammatory bowel disease: an old chestnut or a whole new ballgame?

(2014) Simone Saibeni et al.   Expert Review of Gastroenterology & Hepatology

Risks of Inflammatory Bowel Disease Treatment with Glucocorticosteroids and Aminosalicylates

(2013) Ivanka Curkovic et al.   DIGESTIVE DISEASES

Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study

(2013) Simon P L Travis et al.   GUT

Glucocorticosteroids in the treatment of inflammatory bowel disease and approaches to minimizing systemic activity

(2013) Cosimo Prantera et al.   Therapeutic Advances in Gastroenterology

Once-Daily Budesonide MMX® Extended-Release Tablets Induce Remission in Patients With Mild to Moderate Ulcerative Colitis: Results From the CORE I Study

(2012) William J. Sandborn et al.   GASTROENTEROLOGY

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management

(2012) Axel Dignass et al.   Journal of Crohns & Colitis

Efficacy of 5-Aminosalicylates in Ulcerative Colitis: Systematic Review and Meta-Analysis

(2011) Alexander C Ford et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee

(2010) Asher Kornbluth et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Usefulness of oral beclometasone dipropionate in the treatment of active ulcerative colitis in clinical practice: The RECLICU Study

(2010) Tiago Nunes et al.   Journal of Crohns & Colitis

3g mesalazine granules are superior to 9mg budesonide for achieving remission in active ulcerative colitis: A double-blind, double-dummy, randomised trial

(2010) Volker Gross et al.   Journal of Crohns & Colitis

Clinical trial: Preliminary efficacy and safety study of a new Budesonide-MMX® 9mg extended-release tablets in patients with active left-sided ulcerative colitis

(2009) G.R. D'Haens et al.   Journal of Crohns & Colitis